+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oral Thin Films - Global Strategic Business Report

  • PDF Icon

    Report

  • 197 Pages
  • July 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309860
The global market for Oral Thin Films is estimated at US$3.8 Billion in 2023 and is projected to reach US$8.5 Billion by 2030, growing at a CAGR of 12.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Sublingual Film segment, which is expected to reach US$3.6 Billion by 2030 with a CAGR of 11.6%. The Fast Dissolving Dental/Buccal Film segment is also set to grow at 12.8% CAGR over the next 7 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $1.1 Billion in 2023, and China, forecasted to grow at an impressive 11.8% CAGR to reach $1.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Oral Thin Films Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Oral Thin Films Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Oral Thin Films Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Allergan plc, Aquestive Therapeutics Inc., Indivior plc, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 48 Featured):

  • Allergan plc
  • Aquestive Therapeutics Inc.
  • Indivior plc
  • IntelGenx Corp.
  • LTS Lohmann Therapie-Systeme AG
  • Mylan NV
  • NAL Pharma
  • Novartis AG
  • Pfizer, Inc.
  • Solvay
  • Sumitomo Dainippon Pharma Co., Ltd.
  • ZIM Laboratories Limited

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Oral Thin Films - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Oral Thin Films by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World 7-Year Perspective for Oral Thin Films by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Sublingual Film by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 4: World 7-Year Perspective for Sublingual Film by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Fast Dissolving Dental/Buccal Film by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World 7-Year Perspective for Fast Dissolving Dental/Buccal Film by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World 7-Year Perspective for Schizophrenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 10: World 7-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Opioid Dependence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World 7-Year Perspective for Opioid Dependence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Nausea & Vomiting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World 7-Year Perspective for Nausea & Vomiting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 16: World 7-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World 7-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Drug Store by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World 7-Year Perspective for Drug Store by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 21: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 22: World 7-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for E-Commerce by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 24: World 7-Year Perspective for E-Commerce by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 25: World Oral Thin Films Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 28: USA Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 29: USA 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 30: USA Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 31: USA 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 34: Canada Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 35: Canada 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 36: Canada Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 37: Canada 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
JAPAN
  • Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 40: Japan Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 41: Japan 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 42: Japan Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 43: Japan 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
CHINA
  • Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 44: China Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: China 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 46: China Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 47: China 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 48: China Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 49: China 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
EUROPE
  • Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for Oral Thin Films by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 51: Europe 7-Year Perspective for Oral Thin Films by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 52: Europe Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 53: Europe 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 54: Europe Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 55: Europe 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Europe 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
FRANCE
  • Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 58: France Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 59: France 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 60: France Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 61: France 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 62: France Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: France 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
GERMANY
  • Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 64: Germany Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 65: Germany 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 66: Germany Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 67: Germany 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 68: Germany Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Germany 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
ITALY
  • Table 70: Italy Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 71: Italy 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 72: Italy Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 73: Italy 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 74: Italy Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: Italy 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
UNITED KINGDOM
  • Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 76: UK Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 77: UK 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 78: UK Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 79: UK 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 80: UK Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: UK 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
REST OF EUROPE
  • Table 82: Rest of Europe Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 83: Rest of Europe 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 84: Rest of Europe Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 85: Rest of Europe 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Rest of Europe 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
ASIA-PACIFIC
  • Oral Thin Films Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 89: Asia-Pacific 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 91: Asia-Pacific 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Asia-Pacific 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
REST OF WORLD
  • Table 94: Rest of World Recent Past, Current & Future Analysis for Oral Thin Films by Product Type - Sublingual Film and Fast Dissolving Dental/Buccal Film - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 95: Rest of World 7-Year Perspective for Oral Thin Films by Product Type - Percentage Breakdown of Value Sales for Sublingual Film and Fast Dissolving Dental/Buccal Film for the Years 2024 & 2030
  • Table 96: Rest of World Recent Past, Current & Future Analysis for Oral Thin Films by Disease Indication - Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 97: Rest of World 7-Year Perspective for Oral Thin Films by Disease Indication - Percentage Breakdown of Value Sales for Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting and Other Disease Indications for the Years 2024 & 2030
  • Table 98: Rest of World Recent Past, Current & Future Analysis for Oral Thin Films by Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 99: Rest of World 7-Year Perspective for Oral Thin Films by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Store, Retail Pharmacies and E-Commerce for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Allergan plc
  • Aquestive Therapeutics Inc.
  • Indivior plc
  • IntelGenx Corp.
  • LTS Lohmann Therapie-Systeme AG
  • Mylan NV
  • NAL Pharma
  • Novartis AG
  • Pfizer, Inc.
  • Solvay
  • Sumitomo Dainippon Pharma Co., Ltd.
  • ZIM Laboratories Limited

Table Information